Alpha Investment (ALPC) 10-Q 20 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 10, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	333-198772
Entity Registrant Name	Alpha Investment Inc.
Entity Central Index Key	0001616736
Entity Tax Identification Number	90-0998139
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	200 East Campus View Blvd.
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Columbus
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	43235
City Area Code	305
Local Phone Number	704-3294
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		11,224,401

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 400
Total Current Assets	400
Other Assets:
Loans receivable - related party, net of discounts
Loans receivable, net of discounts
Interest receivable
Total Other Assets
Property and Equipment, net:
Furniture and Equipment, net
Total Property and Equipment	0	0
TOTAL ASSETS	400
Current Liabilities:
Accounts payable	698,718	602,416
Accrued management fees - related party	562,500	450,000
Distribution payable	550,000	460,000
Notes payable - short-term	50,304	39,279
Notes payable - related party	255,592	231,747
Judgments payable	2,662,147	2,518,000
Total Current Liabilities	4,779,261	4,301,442
Payroll Protection Plan Loan
Total Liabilities	4,779,261	4,301,442
Temporary Equity:
Series 2018 Convertible Preferred Stock ($0.0001 par value), net of discounts of $134,247 and $140,169, respectively, 100,000 shares authorized; 36,667 shares issued and outstanding  (liquidation value: $500,000) (See Note 7)	451,864	434,098
Stockholders' Equity:
Common stock, ($0.0001 par value), 100,000,000 shares authorized; 1,224,401 and 9,724,401 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively	1,123	973
Additional paid-in capital	6,039,790	6,012,900
Accumulated deficit	(10,830,641)	(10,398,416)
Total Equity	(4,320,349)	(4,367,028)
Non-controlling interest in variable interest entities	(458,512)	(368,512)
Total Stockholders' Equity	(5,230,725)	(4,735,540)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	400
Series A Convertible Preferred Stock
Stockholders' Equity:
Preferred stock ($0.0001 par value), 20,000,000 shares	17,505	17,505
Series AA Convertible Preferred Stock
Stockholders' Equity:
Preferred stock ($0.0001 par value), 20,000,000 shares	$ 10	$ 10

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	1,224,401	9,724,401
Common stock, shares outstanding	1,224,401	9,724,401
Series 2018 Convertible Preferred Stock
Temporary equity, par value	$ 0.0001	$ 0.0001
Temporary equity, net of discounts	$ 134,247	$ 140,169
Temporary equity, shares authorized	100,000	100,000
Temporary equity, shares issued	36,667	36,667
Temporary equity, shares outstanding	36,667	36,667
Temporary equity, liquidation value	$ 500,000	$ 500,000
Series A Convertible Preferred Stock
Preferred stock, par value	$ 15	$ 15
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	1,167	1,167
Preferred stock, shares outstanding	1,167	1,167
Series AA Convertible Preferred Stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	100,000	100,000
Preferred stock, shares outstanding	100,000	100,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income:
Net investment income - related parties
Net investment income
Total Income
General and Administrative Expenses:
Management fee - related party	37,500	37,500	112,500	112,500
Administrative expenses	25,065	63,556	75,123	186,222
Professional fees	6,800	15,660	51,977	119,092
Total General and Administrative Expenses	69,365	116,716	239,600	417,814
Loss from Operations	(69,365)	(116,716)	(239,600)	(417,814)
Other Expense:
Other income/expense			(144,147)	(2,518,000)
Interest expense, net	(10,237)	(8,662)	(30,713)	(21,787)
Total Other Expense	(10,237)	(8,662)	(174,860)	(2,539,787)
Net Loss	(79,602)	(125,378)	(414,460)	(2,957,601)
Amortization of discounts on Series 2018 preferred stock and redeemable common stock	(5,922)	(5,922)	(17,766)	(17,766)
Net Income Attributable to Non-controlling Interests
Net Loss Attributable to Common Stockholders	$ (85,524)	$ (131,300)	$ (432,226)	$ (2,975,367)
Basic and Diluted Loss Per Share	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.31)
Basic and Diluted Weighted Average Number of  Common Shares Outstanding	11,724,401	9,724,401	10,510,115	9,724,401

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)	Common Stock	Series A Preferred Stock	Series AA Preferred Stock	Paid-In Capital	Non-Controlling Interest	Accumulated Deficit	Total
Beginning balance, value at Dec. 31, 2021	$ 973	$ 17,505	$ 10	$ 5,939,250	$ (248,512)	$ (7,274,955)	$ (1,565,729)
Shares outstanding at Dec. 31, 2021	9,724,401	1,167	100,000
Stock exchange
Stockholder contribution				32,600			32,600
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(126,361)	(126,361)
Ending balance, value at Mar. 31, 2022	$ 973	$ 17,505	$ 10	5,971,850	(278,512)	(7,407,238)	(1,695,412)
Shares outstanding at Mar. 31, 2022	9,724,401	1,167	100,000
Beginning balance, value at Dec. 31, 2021	$ 973	$ 17,505	$ 10	5,939,250	(248,512)	(7,274,955)	(1,565,729)
Shares outstanding at Dec. 31, 2021	9,724,401	1,167	100,000
Net loss							(2,957,601)
Ending balance, value at Sep. 30, 2022	$ 973	$ 17,505	$ 10	6,012,900	(338,512)	(10,250,322)	(4,557,446)
Shares outstanding at Sep. 30, 2022	9,724,401	1,167	100,000
Beginning balance, value at Mar. 31, 2022	$ 973	$ 17,505	$ 10	5,971,850	(278,512)	(7,407,238)	(1,695,412)
Shares outstanding at Mar. 31, 2022	9,724,401	1,167	100,000
Stock exchange
Stockholder contribution				41,050			41,050
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(2,705,862)	(2,705,862)
Ending balance, value at Jun. 30, 2022	$ 973	$ 17,505	$ 10	6,012,900	(308,512)	(10,119,022)	(4,396,146)
Shares outstanding at Jun. 30, 2022	9,724,401	1,167	100,000
Stock exchange
Stockholder contribution
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(125,378)	(125,378)
Ending balance, value at Sep. 30, 2022	$ 973	$ 17,505	$ 10	6,012,900	(338,512)	(10,250,322)	(4,557,446)
Shares outstanding at Sep. 30, 2022	9,724,401	1,167	100,000
Beginning balance, value at Dec. 31, 2022	$ 973	$ 17,505	$ 10	6,012,900	(368,512)	(10,398,416)	(4,735,540)
Shares outstanding at Dec. 31, 2022	9,724,401	1,167	100,000
Stockholder contribution				8,250			8,250
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(249,584)	(249,584)
Ending balance, value at Mar. 31, 2023	$ 973	$ 17,505	$ 10	6,021,150	(398,512)	(10,653,922)	(5,012,796)
Shares outstanding at Mar. 31, 2023	9,724,401	1,167	100,000
Beginning balance, value at Dec. 31, 2022	$ 973	$ 17,505	$ 10	6,012,900	(368,512)	(10,398,416)	(4,735,540)
Shares outstanding at Dec. 31, 2022	9,724,401	1,167	100,000
Net loss							(414,460)
Ending balance, value at Sep. 30, 2023	$ 1,123	$ 17,505	$ 10	6,039,790	(458,512)	(10,830,641)	(5,230,725)
Shares outstanding at Sep. 30, 2023	11,224,401	1,167	100,000
Beginning balance, value at Mar. 31, 2023	$ 973	$ 17,505	$ 10	6,021,150	(398,512)	(10,653,922)	(5,012,796)
Shares outstanding at Mar. 31, 2023	9,724,401	1,167	100,000
Stockholder contribution				8,250			8,250
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(85,273)	(85,273)
Sale of common stock	$ 150			1,350			1,500
Sale of common stock, shares	1,500,000
Ending balance, value at Jun. 30, 2023	$ 1,123	$ 17,505	$ 10	6,030,750	(428,512)	(10,745,117)	(5,124,241)
Shares outstanding at Jun. 30, 2023	11,224,401	1,167	100,000
Stockholder contribution				9,040			9,040
Distributions due to non-controlling interest					(30,000)		(30,000)
Amortization of discount on redeemable preferred stock						(5,922)	(5,922)
Net loss						(79,602)	(79,602)
Sale of common stock
Ending balance, value at Sep. 30, 2023	$ 1,123	$ 17,505	$ 10	$ 6,039,790	$ (458,512)	$ (10,830,641)	$ (5,230,725)
Shares outstanding at Sep. 30, 2023	11,224,401	1,167	100,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net loss	$ (414,460)	$ (2,957,601)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense		237
Accretion of origination fee income
Amortization of deferred loan costs
Payroll protection loan forgiveness
Changes in operating assets and liabilities:
Increase in judgments payable	144,147	1,518,000
Increase in settlements payable		1,000,000
Increase in interest receivable
Increase in accrued management fees - related party	112,500	112,500
Decrease in accounts payable and accrued expenses	96,302	195,965
Increase in interest payable	11,025	2,100
Increase in notes payable - related party	23,845	19,688
Net cash used in operating activities	(26,641)	(109,111)
Cash Flows from Investing Activities:
Net cash from investing activities
Cash Flows from Financing Activities:
Proceeds from short term loan		35,000
Proceeds from sale of stock	1,500
Proceeds from stockholder contribution	25,540	73,650
Net cash provided by (used in) financing activities	27,040	108,650
Net increase (decrease) in cash	400	(461)
Cash and restricted cash at beginning of year		588
Cash and restricted cash at end of year	400	127
Supplemental Disclosure of Cash Flow Information:
Interest
Income Taxes
Schedule of Non-Cash Investing and Financing Activities:
Distribution due to non-controlling interest	90,000	90,000
Amortization of discount on redeemable preferred stock	$ 17,766	$ 17,766

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Alpha Investment Inc, formerly GoGo Baby, Inc. (the “Company”) was incorporated on February 22, 2013 under the laws of the State of Delaware to develop, create, manufacture and market, toys for small children which would be designed to attach to car seats and amuse and entertain children during a drive, without distracting the attention of the driver. The Company, however, encountered significant constraints in raising sufficient capital to fully implement its business plan. To better reflecting management’s shifted focus of the Company’s business to real estate and other commercial lending, on March 30, 2017, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Delaware Secretary of State changing its name from “Gogo Baby, Inc.” to “Alpha Investment Inc.”. The name change and a corresponding change in the Company’s OTC markets trading symbol from GGBY to ALPC received approval from FINRA and became effective as of April 19, 2017. On March 11, 2019, the Company, through Alpha Mortgage Notes I, LLC (the “ SPV Alameda Partners 1,000,000 10,000 Parsons 1,200 On July 21, 2021, the Company and Parsons entered into an Unwinding Agreement (the “Unwinding Agreement“), pursuant to which the joint venture was unwound. Under the Unwinding Agreement, Parsons returned the Series 2020 Preferred Shares to the Company for cancellation and the Company assigned the Interest in Legacy Sand back to Parsons and exchanged mutual releases.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN Future issuances of the Company’s equity or debt securities will be required for the Company to continue to finance its operations and continue as a going concern. The Company’s present revenues are insufficient to meet operating expenses. The financial statements of the Company have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has an accumulated deficit of $ 10,830,641 as of September 30, 2023. During the nine months ended September 30, 2023, the Company used $ 26,641 414,460

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year. accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company, Alpha Mortgage Notes I, LLC, which is controlled by the Company through its 90 Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingencies. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results. Cash and Cash Equivalents Cash equivalents include short-term, highly liquid investments with maturities of three months or less at the time of acquisition. As of September 30, 2023, the Company has $ 400 Loans Receivable, net and Allowance for Losses The Company records its investments in loans receivable at the lower of cost or fair value. Costs are the gross loan receivables less unamortized costs of issuance and deferred origination fees. Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans. When a loan receivable is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria. The Company maintains an allowance for loan losses on its investments in real estate loans receivable for estimated credit impairment. Management’s estimate of losses is based on several factors including the types and dollar amounts of loans in the portfolio, adverse situations that may affect the borrower’s ability to repay, prevailing economic conditions and the underlying collateral securing the loan. Additions to the allowance are provided through a charge to earnings and are based on an assessment of certain factors, which may indicate estimated losses on the loans. Actual losses on loans are recorded first as a reduction to the allowance for loan losses. Generally, subsequent recoveries of amounts previously charged off are recognized as income. Estimating allowances for loan losses requires significant judgment about the underlying collateral, including liquidation value, condition of the collateral, competency and cooperation of the related borrower and specific legal issues that affect loan collections or taking possession of the property on an individual loan receivable basis. Management has established an allowance of $ 1,633,380 Property and Equipment Property and equipment are stated at cost. Equipment and fixtures will be depreciated using the straight-line method over the estimated asset lives, 5 0 0 237 Income Taxes The Company accounts for its income taxes in accordance with FASB Accounting Standards Codification (“ASC”) No. 740, "Income Taxes". Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment. Accounting for Uncertainty in Income Taxes The Company applies the provisions of ASC Topic 740-10-25, Income Taxes – Overall – Recognition (“ASC Topic 740-10-25”) with respect to the accounting for uncertainty of income tax positions. ASC Topic 740-10-25 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-25 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of September 30, 2023, tax years since 2014 remain open for IRS audit. The Company has received no notice of audit from the Internal Revenue Service for any of the open tax years. Revenue Recognition and Investment Income Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans. The Company records interest income in accordance with ASC subtopic 835-30 "Imputation of Interest", using the effective interest method. The Company has no income for the nine months ended September 30, 2023 and 2022. When a loan is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria. The Company suspends recognizing interest income when it is probable that the Company will be unable to collect all payments according to the contractual terms of the underlying agreements. Management considers all information available in assessing collectability. Collectability is measured on a receivable-by-receivable basis by either the present value of estimated future cash flows discounted at the effective rate, the observable market price for the receivable or the fair value of the collateral if the receivable is collateral dependent. Large groups of smaller balance homogeneous receivables, such as pre-settlement funding transactions, are collectively assessed for collectability. Receivables, including those arising from the sale of loan origination services, is charged off when in the Company's judgment, the receivable or portion of the receivable is considered uncollectible. Payments received on past due receivables and finance receivables the Company has suspended recognizing interest income on are applied first to principal and then to accrued interest. Interest income on past due receivables and finance receivables, if received, is recorded using the cash basis method of accounting. Additionally, the Company generally does not resume recognition of interest income once it has been suspended. At December 31, 2022, the Company evaluated the collectability of its loans and lines of credit receivable, in light of economic conditions during the Covid-19 pandemic, established an allowance account to bring these to $ 0 Variable Interest Entity Paris Med Omega Commercial Finance Corp. Variable Interest Entity The Company holds a 10 90 0 Fair Value The carrying amounts reported in the balance sheet for cash, accounts payable and notes payable approximate their estimated fair market value based on the short-term maturity of this instrument. The carrying value of the Company’s loans receivable approximate fair value because their terms approximate market rates. Net Loss Per Share Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding for the year. Dilutive loss per share reflects the potential dilution of securities that could share in the losses of the Company. 36,667 Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and loans receivable. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. Management has established an allowance of $ 1,633,380 Recently Issued and Adopted Accounting Pronouncements Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

LOANS RECEIVABLE, NET

LOANS RECEIVABLE, NET	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
LOANS RECEIVABLE, NET	NOTE 4 – LOANS RECEIVABLE, NET Loans Receivable - Related Parties Loan Agreement with Partners South Holdings LLC (Revolving Line of Credit) On August 28, 2017 the Company entered into a loan agreement with Partners South Holdings LLC (“Borrower”), which is owned by Timothy R. Fussell, President, Chairman of the Board and a director of the Company, for a revolving line of credit in the maximum principal sum of $ 3,600,000 657,500 3.5 477,500 180,000 420,000 0 20,667 0 0 Loan Agreement with Partners South Properties Corporation (Revolving Line of Credit) On August 28, 2017, the Company entered into a loan agreement with Partners South Properties Corporation (“Borrower”), which is owned by Timothy R. Fussell, President, Chairman of the Board and a director of the Company, for a revolving line of credit in the maximum principal sum of $ 5,000,000 250,000 August 31, 2022 3.5 250,000 250,000 0 Loans Receivable Paris Med On May 2, 2018, the Company and Paris Med entered into agreements, pursuant to which Paris Med agreed to provide project financing in the amount of $ 158,216,541 1) Construction financing in the amount of $ 90,204,328 maturing in 10 years 558,000 92,400 2) Equipment financing note in the amount of $ 24,715,986 3) Operations financing, business line of credit in the amount of $ 23,932,625 maturing in 10 years 4) The notes are secured by the assignment of leases and fixed assets related to the project. In December 2022, the Company established a full reserve against this loan until such time as the loan is repaid. As of September 30, 2023 and December 31, 2022, the receivable balance is $0.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5 - COMMITMENTS AND CONTINGENCIES Alpha Mortgage Notes, LLC In exchange for its 90% interest in the Alpha Mortgage Notes, LLC, ("SPV") the Company is required to contribute 4,015,667 shares of common stock to be used by the SPV for the purchase of performing notes for the SPV. The SPV is required to make monthly distributions to its 10% member of $10,000 up until the time a purchase of the performing notes are made, and upon the acquisition of the six mortgages specified in the SPV's operating agreement, monthly payments of $150,000 per month from gross interest income received for 30 months; and 20% of any other future note purchases. The 10% partner will also receive an amount equal to 1% of the principal amounts received on each loan. 90,000 550,000 Litigation We are currently involved in the following legal proceedings: Steven T. Matthiesen and Joanna K. Matthiesen, jointly and severally v. Tmothy Fussell et al. In the United States District Court, Southern District of Florida, Case No. 21CV62334. This breach of contract matter resulted in a default judgment against the Defendants in 2022 of $ 1,514,000 Pending Litigation Judicial Ruling Fusion Lodgings LLC v. PLC et al, In the District Court, 160 th 1,000,000 Supplemental complaint for financial relief in regards to collections, In the circuit court of the eleventh judicial circuit in and for Miami-Dade County, Florida, case #2021-20869-CA01, seeking $ 144,147 Advisory Agreement In June 2019, the Company entered into an advisory agreement, pursuant to which it agreed to compensate a third-party advisor a percentage of future capital raises facilitated by the advisor. Compensation includes non-refundable cash, cash compensation based on a percentage of capital raised. The advisor may elect to receive certain percentage-based fees in the form of equity. Upon the closing of a transaction, the advisor will receive five-year warrants to purchase a number of shares of common stock equal to 8% of the number of shares issue in the transaction at a strike price of the transaction value as defined the agreement. As of the date of this report, no amounts have been earned and no equity instruments have been issued as transaction-based fees pursuant to this agreement.

NOTE PAYABLE SHORT-TERM

NOTE PAYABLE SHORT-TERM	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
NOTE PAYABLE SHORT-TERM	NOTE 6 – NOTE PAYABLE SHORT-TERM On June 29, 2022, the Company issued a promissory note in the amount of $ 35,000 24 December 29, 2022 50,304 39,279 11,025 4,279

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS Loans receivable The Company has extended lines of credit and loans to related parties. See Note 4. Management Fee The Company pays its parent company, Omega Commercial Finance Corp (“Omega”) management fees pursuant to a corporate governance management agreement executed on June 1, 2017. Omega is to provide services related to facilitating the introduction of potential investors for compensation not to exceed $300,000 per year. The agreement remains in effect until cancelled by Omega. 112,500 562,500 450,000 Note Payable – related party On October 14, 2020, the Company issue a promissory note in the amount of $ 175,000 10 December 15, 2020 255,592 231,747

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 8 – STOCKHOLDERS’ EQUITY Temporary Equity On November 27, 2017, 16,667 15.00 250,000 The shares have 350,000 warrants attached, each warrant entitling the holder to one additional share with an exercise date of up to 5 years from the issuance date of the shares. The preferred stock is mandatorily redeemable 10 years after issuance. 20,000 15 236,897 451,864 434,098 98,715 116,481 Preferred Stock Series A Convertible Preferred Stock. In November 2017, the Company’s board of directors designated 100,000 15.00 1,167 Series AA Convertible Preferred Issuance In February, 2021, Alpha issued 100,000 100,000 Capital Contributions During the nine months ended September 30, 2023, Omega Commercial Finance Corp made a cash contribution to the Company of $ 25,540 Common Stock On May 10, 2023, Omega Worldwide, an unaffiliated company, purchased 1,500,000 1,500 0.001 Common Stock Warrants As of September 30, 2023, there are no outstanding warrants. On September 9, 2022, warrants outstanding to acquire 350,000 As of September 30, 2022, there are warrants outstanding to purchase 170,000 15.00 five December 14, 2022

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no such events that warrant disclosure or recognition in the consolidated financial statements presented herein.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year. accepted in the United States of America have been condensed or omitted. It is suggested that these condensed financial statements be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for future periods or the full year.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company, Alpha Mortgage Notes I, LLC, which is controlled by the Company through its 90
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods presented. The Company is required to make judgments and estimates about the effect of matters that are inherently uncertain. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long-lived assets, deferred income tax asset valuations and loss contingencies. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Although, we believe our judgments and estimates are appropriate, actual future results may be different; if different assumptions or conditions were to prevail, the results could be materially different from our reported results.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents include short-term, highly liquid investments with maturities of three months or less at the time of acquisition. As of September 30, 2023, the Company has $ 400
Loans Receivable, net and Allowance for Losses	Loans Receivable, net and Allowance for Losses The Company records its investments in loans receivable at the lower of cost or fair value. Costs are the gross loan receivables less unamortized costs of issuance and deferred origination fees. Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans. When a loan receivable is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria. The Company maintains an allowance for loan losses on its investments in real estate loans receivable for estimated credit impairment. Management’s estimate of losses is based on several factors including the types and dollar amounts of loans in the portfolio, adverse situations that may affect the borrower’s ability to repay, prevailing economic conditions and the underlying collateral securing the loan. Additions to the allowance are provided through a charge to earnings and are based on an assessment of certain factors, which may indicate estimated losses on the loans. Actual losses on loans are recorded first as a reduction to the allowance for loan losses. Generally, subsequent recoveries of amounts previously charged off are recognized as income. Estimating allowances for loan losses requires significant judgment about the underlying collateral, including liquidation value, condition of the collateral, competency and cooperation of the related borrower and specific legal issues that affect loan collections or taking possession of the property on an individual loan receivable basis. Management has established an allowance of $ 1,633,380
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Equipment and fixtures will be depreciated using the straight-line method over the estimated asset lives, 5 0 0 237
Income Taxes	Income Taxes The Company accounts for its income taxes in accordance with FASB Accounting Standards Codification (“ASC”) No. 740, "Income Taxes". Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax balances. Deferred tax assets and liabilities are measured using enacted or substantially enacted tax rates expected to apply to the taxable income in the years in which those differences are expected to be recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the date of enactment or substantive enactment.
Accounting for Uncertainty in Income Taxes	Accounting for Uncertainty in Income Taxes The Company applies the provisions of ASC Topic 740-10-25, Income Taxes – Overall – Recognition (“ASC Topic 740-10-25”) with respect to the accounting for uncertainty of income tax positions. ASC Topic 740-10-25 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740-10-25 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. As of September 30, 2023, tax years since 2014 remain open for IRS audit. The Company has received no notice of audit from the Internal Revenue Service for any of the open tax years.
Revenue Recognition and Investment Income	Revenue Recognition and Investment Income Origination fees collected at the time of investment are recorded against the loans receivable and amortized into net interest income over the lives of the related loans. Issuance costs incurred are capitalized along with the initial investment and amortized against net interest income over the lives of the related loans. The Company records interest income in accordance with ASC subtopic 835-30 "Imputation of Interest", using the effective interest method. The Company has no income for the nine months ended September 30, 2023 and 2022. When a loan is placed on non-accrual status, the related interest receivable is charged to bad debt of the current period. If a non-accrual loan is returned to accrual status, the accrued interest existing at the date the residential loan is placed on non-accrual status and interest during the non-accrual period are recorded as interest income as of the date the loan no longer meets the non-accrual criteria. The Company suspends recognizing interest income when it is probable that the Company will be unable to collect all payments according to the contractual terms of the underlying agreements. Management considers all information available in assessing collectability. Collectability is measured on a receivable-by-receivable basis by either the present value of estimated future cash flows discounted at the effective rate, the observable market price for the receivable or the fair value of the collateral if the receivable is collateral dependent. Large groups of smaller balance homogeneous receivables, such as pre-settlement funding transactions, are collectively assessed for collectability. Receivables, including those arising from the sale of loan origination services, is charged off when in the Company's judgment, the receivable or portion of the receivable is considered uncollectible. Payments received on past due receivables and finance receivables the Company has suspended recognizing interest income on are applied first to principal and then to accrued interest. Interest income on past due receivables and finance receivables, if received, is recorded using the cash basis method of accounting. Additionally, the Company generally does not resume recognition of interest income once it has been suspended. At December 31, 2022, the Company evaluated the collectability of its loans and lines of credit receivable, in light of economic conditions during the Covid-19 pandemic, established an allowance account to bring these to $ 0
Variable Interest Entity	Variable Interest Entity Paris Med Omega Commercial Finance Corp. Variable Interest Entity The Company holds a 10 90 0
Fair Value	Fair Value The carrying amounts reported in the balance sheet for cash, accounts payable and notes payable approximate their estimated fair market value based on the short-term maturity of this instrument. The carrying value of the Company’s loans receivable approximate fair value because their terms approximate market rates.
Net Loss Per Share	Net Loss Per Share Basic loss per share is computed by dividing the net loss available to common stockholders by the weighted average number of common shares outstanding for the year. Dilutive loss per share reflects the potential dilution of securities that could share in the losses of the Company. 36,667
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and loans receivable. The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. Management has established an allowance of $ 1,633,380
Recently Issued and Adopted Accounting Pronouncements	Recently Issued and Adopted Accounting Pronouncements Recent accounting pronouncements that the Company has adopted or that will be required to adopt in the future are summarized below. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)	9 Months Ended	12 Months Ended
	Sep. 30, 2023 USD ($)	Dec. 31, 2019 USD ($)	Jul. 30, 2020 a
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Distributions payable to real estate partnerships	$ 90,000
Joint Venture | Parsons Energy Group, LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Leasehold mining rights, acres | a			1,200
Alpha Investment Inc. | Alpha Mortgage Notes I, LLC
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Proceeds from contributed capital		$ 1,000,000
Distributions payable to real estate partnerships		$ 10,000

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 10,830,641						$ 10,830,641		$ 10,398,416
Net cash used in operating activities							26,641	$ 109,111
Net income loss	$ 79,602	$ 85,273	$ 249,584	$ 125,378	$ 2,705,862	$ 126,361	$ 414,460	$ 2,957,601

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash	$ 400
Allowance for doubtful accounts	$ 1,633,380		1,633,380
Property and equipment, estimated useful life	5 years
Property and equipment	$ 0		0
Property and equipment, depreciation expense	0	$ 237
Allowance for accounts and financing receivables			0
Variable interest entity, assets	$ 400
Shares Underlying Convertible Preferred Stock
Shares excluded from computation of diluted loss per share	36,667	36,667
Paris Med | Omega Commercial Finance Corp.
Variable interest entity, ownership percentage in Paris MED	90%
Paris Med | Variable Interest Entity
Variable interest entity, assets			$ 0
Alpha Investment Inc. | Paris Med
Variable interest entity, ownership percentage in Paris MED	10%
Alpha Investment Inc. | Alpha Mortgage Notes I, LLC
Managing member, ownership interest	90%

LOANS RECEIVABLE, NET (Details

LOANS RECEIVABLE, NET (Details Narrative) - USD ($)		1 Months Ended	6 Months Ended		12 Months Ended
	May 02, 2018	Aug. 28, 2017	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2023	Dec. 31, 2022	Jan. 28, 2020	Nov. 02, 2019
Partners South Holdings LLC
Financing Receivable, Past Due [Line Items]
Loan receivable in the form of a revolving line of credit		$ 3,600,000					$ 0	$ 0
Reduction of loan receivable in the form of a revolving line of credit									$ 657,500
Interest rate		3.50%
Advances of loan					$ 477,500
Unamortized origination fees					180,000
Deferred issuance costs					420,000
Amortization of issuance costs			$ 0	$ 20,667
Deferred issuance costs			$ 0		0
Partners South Properties Corporation
Financing Receivable, Past Due [Line Items]
Loan receivable in the form of a revolving line of credit		$ 5,000,000
Reduction of loan receivable in the form of a revolving line of credit										$ 250,000
Interest rate		3.50%
Maturity date		Aug. 31, 2022
Loan receivable					$ 250,000
Loan receivable, balance							$ 0	$ 0
Paris Med
Financing Receivable, Past Due [Line Items]
Project financing to an unrelated third party	$ 158,216,541
Paris Med | Construction Loans [Member]
Financing Receivable, Past Due [Line Items]
Financing receivable, commitment	$ 90,204,328
Financing receivable, maturity	maturing in 10 years
Advances on construction loan						$ 558,000
Deferred income						$ 92,400
Paris Med | Equipment Financing
Financing Receivable, Past Due [Line Items]
Financing receivable, commitment	$ 24,715,986
Paris Med | Operations Financing
Financing Receivable, Past Due [Line Items]
Financing receivable, commitment	$ 23,932,625
Financing receivable, maturity	maturing in 10 years

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2019	Dec. 31, 2022
Loss Contingencies [Line Items]
Distribution payable to noncontrolling interest	$ 90,000
Distributions payable	550,000		$ 460,000
Judicial Ruling
Loss Contingencies [Line Items]
Default judgement	1,514,000
Judicial Ruling #2
Loss Contingencies [Line Items]
Default judgement	1,000,000
Pending Litigation
Loss Contingencies [Line Items]
Damages sought, value	144,147
Alpha Investment Inc. | Alpha Mortgage Notes I, LLC (SPV)
Loss Contingencies [Line Items]
Distribution policy, description		In exchange for its 90% interest in the Alpha Mortgage Notes, LLC, ("SPV") the Company is required to contribute 4,015,667 shares of common stock to be used by the SPV for the purchase of performing notes for the SPV. The SPV is required to make monthly distributions to its 10% member of $10,000 up until the time a purchase of the performing notes are made, and upon the acquisition of the six mortgages specified in the SPV's operating agreement, monthly payments of $150,000 per month from gross interest income received for 30 months; and 20% of any other future note purchases. The 10% partner will also receive an amount equal to 1% of the principal amounts received on each loan.
Distributions payable	$ 550,000

NOTE PAYABLE SHORT-TERM (Detail

NOTE PAYABLE SHORT-TERM (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Short-Term Debt [Line Items]
Maturity date			Dec. 29, 2022
Interest expense	$ 10,237	$ 8,662		$ 30,713	$ 21,787
Notes Payable, Other Payables [Member]
Short-Term Debt [Line Items]
Note payable	$ 50,304		$ 35,000	50,304		$ 39,279
Interest rate			24%
Interest expense				$ 11,025	$ 4,279

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended
	Oct. 14, 2020	Jun. 30, 2017	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022
Related Party Transaction [Line Items]
Management fee payable			$ 562,500	$ 450,000
Note payable, related party			255,592	231,747
Partners South Holdings LLC
Related Party Transaction [Line Items]
Note payable	$ 175,000
Interest rate	10%
Maturity date	Dec. 15, 2020
Note payable, related party			255,592	231,747
Corporate Governance Management Agreement | Omega Commercial Finance Corp. and Omega Streets Capital
Related Party Transaction [Line Items]
Commitment, description		Omega is to provide services related to facilitating the introduction of potential investors for compensation not to exceed $300,000 per year. The agreement remains in effect until cancelled by Omega.
Accrued management fees			112,500		$ 112,500
Management fee payable			$ 562,500	$ 450,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)			1 Months Ended	9 Months Ended
	May 10, 2023	Sep. 09, 2022	Nov. 27, 2017	Sep. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Feb. 28, 2021	Jan. 15, 2018	Nov. 30, 2017
Class of Stock [Line Items]
Proceeds from issuance of equity				$ 1,500
Convertible Preferred Stock, net of discount				$ 451,864	$ 434,098
Preferred stock, shares authorized				20,000,000	20,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Number of warrants expired		350,000
Number of warrants outstanding						170,000
Exercise price						$ 15
Term of warrants						5 years
Number of warrants outstanding						Dec. 14, 2022
Omega Worldwide LLC
Class of Stock [Line Items]
Sale of shares	1,500,000
Sale of shares, value	$ 1,500
Sale of shares, price per share	$ 0.001
Omega Commercial Finance Corp.
Class of Stock [Line Items]
Capital contributions				$ 25,540
Series A Convertible Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized				100,000	100,000				100,000
Preferred stock, par value				$ 15	$ 15				$ 15
Preferred stock, shares outstanding				1,167	1,167
Series AA Convertible Preferred Stock
Class of Stock [Line Items]
Preferred stock, shares authorized				100,000	100,000		100,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares outstanding				100,000	100,000
Series 2018 Convertible Preferred Stock
Class of Stock [Line Items]
Temporary equity, shares issued			16,667
Temporary equity, par value			$ 15
Proceeds from issuance of equity			$ 250,000
Temporary equity, additional disclosure			The shares have 350,000 warrants attached, each warrant entitling the holder to one additional share with an exercise date of up to 5 years from the issuance date of the shares. The preferred stock is mandatorily redeemable 10 years after issuance.
Amortization of discount			$ 236,897
Convertible Preferred Stock, net of discount				$ 451,864	$ 434,098
Unamortized discount				$ 98,715	$ 116,481
Series 2018 Convertible Preferred Stock | Partners South Holdings LLC
Class of Stock [Line Items]
Temporary equity, shares issued								20,000
Temporary equity, par value								$ 15